Celerion is pleased to announce the appointment of John Horkulak as Executive Director, Eurasian Site Operations. Mr. Horkulak will lead the efforts to further expand the company’s early phase patient capabilities in Europe and Asia.
The appointment of Mr. Horkulak continues to reinforce Celerion’s commitment to accelerating drug development through Applied Translational Medicine. Incorporating patients earlier into clinical research programs continues to be an important step in providing better information, faster, during the drug development process.
Help employers find you! Check out all the jobs and post your resume.
